文章名稱引用次數

• Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party141
• Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia112
• GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts86
• Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms76
• PD-1 expression and clinical PD-1 blockade in B-cell lymphomas65
• Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial59
• A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 1040355
• CD38 antibodies in multiple myeloma: back to the future52
• Iron deficiency51
• Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy48